INVO Fertility, Inc.
Key Metrics
- Previous Close
- $0.90
- 52-Week Range
- $0.81 – $84.40
- Market Cap
- $3.93M
- P/E (TTM)
- 0.01
- EPS (TTM)
- 127.95
- Dividend Yield
- 0.00%
Advanced Metrics
- Price/Book
- 0.12
- PEG Ratio
- —
- Return on Equity
- -72.70%
- Return on Assets
- -16.41%
- Gross Margin
- 35.28%
- Operating Margin
- -59.28%
- Profit Margin
- -92.30%
- Current Ratio
- 0.71
- Debt/Equity
- 0.24
- Total Debt
- $3.92M
- Free Cash Flow
- $-5.35M
- Revenue Growth
- 16.70%
- Earnings Growth
- —
- Enterprise Value
- $2.73M
Market Snapshot
About
INVO Fertility, Inc. is a medical device company focused on providing affordable fertility treatment options. The company's proprietary INVOcell device enables intravaginal culture, offering a more natural and cost-effective approach to in vitro fertilization (IVF). The INVOcell system allows fertilization and early embryo development to occur inside the woman's body rather than in a laboratory incubator. INVO Fertility aims to make fertility treatments more accessible to patients who cannot afford traditional IVF procedures, particularly in underserved markets.